In 2023, actual bacteriologically confirmed pulmonary tuberculosis cases in China stood at a lower rate compared to forecasted years, indicating an increasing trend. From 2024 to 2028, forecasts suggest a year-on-year increase of slightly over 1% annually, reflecting a consistent rise in cases from approximately 290,000 to 300,000 cases. This is an indicator of either an increasing prevalence or improved detection rates. The compound annual growth rate (CAGR) over the five-year period accounts for an average increase of roughly 0.88% per year.
Future trends to monitor include advancements in medical technology, public health strategies, and vaccination efforts, as they will significantly influence tuberculosis control and potentially alter forecasted trends. Additionally, observing socio-economic changes and their impact on healthcare access in China will be crucial.
